Stock Track | Neogen Corp Plummets 8.49% as Q4 Earnings Miss Estimates, Reports Massive Net Loss

Stock Track
Jul 29

Neogen Corp (NEOG) shares plummeted 8.49% in Tuesday's trading session following the release of its fourth-quarter 2025 financial results, which fell significantly short of analyst expectations and revealed a substantial net loss.

The food and animal safety products company reported adjusted earnings per share of $0.05 for the quarter, missing the analyst consensus estimate of $0.09 by 44.44%. This marks a steep 50% decrease from the $0.10 per share earned in the same period last year. More alarmingly, Neogen posted a staggering net loss of $612.196 million for the quarter, equivalent to -$2.82 per share, which appears to be the primary driver behind the sharp stock decline.

Despite the earnings disappointment, Neogen's quarterly revenue of $225.459 million slightly exceeded analyst estimates of $221.923 million. However, this still represented a 4.79% decrease compared to the previous year's $236.794 million. Looking ahead, the company provided guidance for fiscal year 2026, projecting revenue in the range of $820 million to $840 million and adjusted EBITDA between $165 million and $175 million. However, these forward-looking projections seem to have done little to alleviate investor concerns about the company's current performance, as reflected in the significant stock price drop.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10